The FTC is “seriously weighing” a challenge to Cross Country Healthcare’s (CCRN) deal to be acquired, reported CTFN, sources tell The Fly.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCRN:
- Cross Country Healthcare price target lowered to $16.50 from $18.61 at UBS
- Cross Country Healthcare Reports Q1 2025 Financial Results
- Cautious Hold Rating for Cross Country Healthcare Amid Revenue Decline and Market Challenges
- Cross Country Healthcare reports Q1 adjusted EPS 6c, consensus 7c
- CCRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?